Entrada Therapeutics Inc (TRDA)
17.62
+0.02
(+0.09%)
USD |
NASDAQ |
Nov 04, 13:15
Entrada Therapeutics 1 Year Total Returns (Daily): 13.55% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 13.55% |
October 31, 2024 | 7.06% |
October 30, 2024 | 12.10% |
October 29, 2024 | 19.17% |
October 28, 2024 | 19.79% |
October 25, 2024 | 25.02% |
October 24, 2024 | 6.92% |
October 23, 2024 | 11.94% |
October 22, 2024 | 16.37% |
October 21, 2024 | 17.66% |
October 18, 2024 | 15.12% |
October 17, 2024 | 13.60% |
October 16, 2024 | 19.08% |
October 15, 2024 | 33.82% |
October 14, 2024 | 36.11% |
October 11, 2024 | 16.85% |
October 10, 2024 | 1.22% |
October 09, 2024 | 13.47% |
October 08, 2024 | 10.37% |
October 07, 2024 | 11.38% |
October 04, 2024 | 9.42% |
October 03, 2024 | 7.52% |
October 02, 2024 | 9.70% |
October 01, 2024 | 1.27% |
September 30, 2024 | 1.14% |
Date | Value |
---|---|
September 27, 2024 | 6.13% |
September 26, 2024 | 5.98% |
September 25, 2024 | 0.80% |
September 24, 2024 | 6.80% |
September 23, 2024 | 1.04% |
September 20, 2024 | 3.38% |
September 19, 2024 | 4.31% |
September 18, 2024 | -4.68% |
September 17, 2024 | -14.85% |
September 16, 2024 | -12.51% |
September 13, 2024 | 4.38% |
September 12, 2024 | 1.09% |
September 11, 2024 | 1.09% |
September 10, 2024 | 3.30% |
September 09, 2024 | 5.47% |
September 06, 2024 | 6.63% |
September 05, 2024 | 8.84% |
September 04, 2024 | -0.06% |
September 03, 2024 | 1.56% |
August 30, 2024 | 9.53% |
August 29, 2024 | 1.21% |
August 28, 2024 | -1.92% |
August 27, 2024 | 4.83% |
August 26, 2024 | 6.15% |
August 23, 2024 | 0.43% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-56.02%
Minimum
Nov 21 2022
127.8%
Maximum
Apr 13 2023
16.37%
Average
7.52%
Median
May 03 2024
1 Year Total Returns (Daily) Benchmarks
Fulcrum Therapeutics Inc | -14.40% |
Sarepta Therapeutics Inc | 61.12% |
Catalyst Pharmaceuticals Inc | 73.18% |
Vertex Pharmaceuticals Inc | 27.56% |
Regenxbio Inc | -38.06% |